Jennifer E. Cook, Director at BridgeBio Pharma, Inc. (BBIO), sold 148,589 shares at $84.00 ($13.2M) on 2026-07-09, disclosed to the SEC on 2026-07-13.
Scheduled sale ($13.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.00 | 36,167 | $3.0M | 23.1% |
| 2 | $90.00 | 112,422 | $10.1M | 76.9% |
| Total | $88.54 avg | 148,589 | $13.2M | 100% |
| Filing → |
| DNLI | SELL | 2024-06-10 | $32K | — | Filing → |
| JAZZ | SELL | 2023-12-06 | $50K | — | Filing → |
| JAZZ | SELL | 2023-08-15 | $343K | — | Filing → |